BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1161 related articles for article (PubMed ID: 11513169)

  • 1. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
    Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
    Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numerical chromosomal abnormality in gastric MALT lymphoma and diffuse large B-cell lymphoma.
    Watanobe I; Takamori S; Kojima K; Fukasawa M; Beppu T; Futagawa S; Hirai S
    J Gastroenterol; 2002; 37(9):691-6. PubMed ID: 12375141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancerogenesis in Helicobacter pylori infected stomach--role of growth factors, apoptosis and cyclooxygenases.
    Konturek PC; Konturek SJ; Pierzchalski P; Bielański W; Duda A; Marlicz K; Starzyńska T; Hahn EG
    Med Sci Monit; 2001; 7(5):1092-107. PubMed ID: 11535962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas.
    Peng H; Ranaldi R; Diss TC; Isaacson PG; Bearzi I; Pan L
    J Pathol; 1998 Aug; 185(4):409-12. PubMed ID: 9828840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma.
    Iwano M; Watanabe N; Matsushima Y; Seno H; Oki K; Sakurai T; Inagaki H; Okazaki K; Chiba T
    Am J Gastroenterol; 2006 Dec; 101(12):2878-83. PubMed ID: 17026570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.
    Mitchell HM; Hazell SL; Li YY; Hu PJ
    Am J Gastroenterol; 1996 Sep; 91(9):1785-8. PubMed ID: 8792699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
    Akamatsu T; Mochizuki T; Okiyama Y; Matsumoto A; Miyabayashi H; Ota H
    Helicobacter; 2006 Apr; 11(2):86-95. PubMed ID: 16579838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
    Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
    Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
    Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication.
    Tari A; Asaoku H; Kashiwado K; Yoshino T; Kitadai Y; Tanaka S; Fujihara M
    Dig Endosc; 2009 Oct; 21(4):219-27. PubMed ID: 19961519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological and clinical predictive value of determination of tissue CagA status by PCR in Helicobacter pylori infected patients; results of the large population based study in western Turkey.
    Saruç M; Demir MA; Küçükmetin N; Kandiloglu AR; Akarca US; Yüceyar H
    Hepatogastroenterology; 2002; 49(45):878-81. PubMed ID: 12064012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease.
    Miehlke S; Yu J; Schuppler M; Frings C; Kirsch C; Negraszus N; Morgner A; Stolte M; Ehninger G; Bayerdörffer E
    Am J Gastroenterol; 2001 Apr; 96(4):1008-13. PubMed ID: 11316139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.